United States Facial Injectable Market Report & Forecast 2021-2027
SKU ID : QYR-19702191 | Publishing Date : 14-Dec-2021 | No. of pages : 94
Detailed TOC of United States Facial Injectable Market Report & Forecast 2021-2027
1 Introduction to Research & Analysis Reports1.1 Facial Injectable Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Facial Injectable Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Facial Injectable Overall Market Size
2.1 United States Facial Injectable Market Size: 2021 VS 2027
2.2 United States Facial Injectable Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Facial Injectable Players in United States Market
3.2 Top United States Facial Injectable Companies Ranked by Revenue
3.3 United States Facial Injectable Revenue by Companies
3.4 Top 3 and Top 5 Facial Injectable Companies in United States Market, by Revenue in 2020
3.5 Companies Facial Injectable Product Type
3.6 Tier 1, Tier 2 and Tier 3 Facial Injectable Players in United States Market
3.6.1 List of Tier 1 Facial Injectable Companies in United States
3.6.2 List of Tier 2 and Tier 3 Facial Injectable Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Facial Injectable Market Size Markets, 2021 & 2027
4.1.2 Hyaluronic Acid
4.1.3 Collagen
4.1.4 Botulinum Toxin
4.1.5 Polymers
4.1.6 Particles
4.2 By Type - United States Facial Injectable Revenue & Forecasts
4.2.1 By Type - United States Facial Injectable Revenue, 2016-2021
4.2.2 By Type - United States Facial Injectable Revenue, 2022-2027
4.2.3 By Type - United States Facial Injectable Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Facial Injectable Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research
5.1.5 Others
5.2 By Application - United States Facial Injectable Revenue & Forecasts
5.2.1 By Application - United States Facial Injectable Revenue, 2016-2021
5.2.2 By Application - United States Facial Injectable Revenue, 2022-2027
5.2.3 By Application - United States Facial Injectable Revenue Market Share, 2016-2027
6 Facial Injectable Companies Profiles
6.1 Bloomega BioTechnology
6.1.1 Bloomega BioTechnology Company Details
6.1.2 Bloomega BioTechnology Business Overview
6.1.3 Bloomega BioTechnology Facial Injectable Introduction
6.1.4 Bloomega BioTechnology Facial Injectable Revenue in United States Market (2016-2021)
6.1.5 Bloomega BioTechnology Recent Developments
6.2 Allergan
6.2.1 Allergan Company Details
6.2.2 Allergan Business Overview
6.2.3 Allergan Facial Injectable Introduction
6.2.4 Allergan Facial Injectable Revenue in United States Market (2016-2021)
6.2.5 Allergan Recent Developments
6.3 Merz Pharma
6.3.1 Merz Pharma Company Details
6.3.2 Merz Pharma Business Overview
6.3.3 Merz Pharma Facial Injectable Introduction
6.3.4 Merz Pharma Facial Injectable Revenue in United States Market (2016-2021)
6.3.5 Merz Pharma Recent Developments
6.4 Bausch Health
6.4.1 Bausch Health Company Details
6.4.2 Bausch Health Business Overview
6.4.3 Bausch Health Facial Injectable Introduction
6.4.4 Bausch Health Facial Injectable Revenue in United States Market (2016-2021)
6.4.5 Bausch Health Recent Developments
6.5 Galderma
6.5.1 Galderma Company Details
6.5.2 Galderma Business Overview
6.5.3 Galderma Facial Injectable Introduction
6.5.4 Galderma Facial Injectable Revenue in United States Market (2016-2021)
6.5.5 Galderma Recent Developments
6.6 Integra Lifesciences
6.6.1 Integra Lifesciences Company Details
6.6.2 Integra Lifesciences Business Overview
6.6.3 Integra Lifesciences Facial Injectable Introduction
6.6.4 Integra Lifesciences Facial Injectable Revenue in United States Market (2016-2021)
6.6.5 Integra Lifesciences Recent Developments
6.7 Tei Biosciences
6.7.1 Tei Biosciences Company Details
6.7.2 Tei Biosciences Business Overview
6.7.3 Tei Biosciences Facial Injectable Introduction
6.7.4 Tei Biosciences Facial Injectable Revenue in United States Market (2016-2021)
6.7.5 Tei Biosciences Recent Developments
6.8 Fibrogen
6.8.1 Fibrogen Company Details
6.8.2 Fibrogen Business Overview
6.8.3 Fibrogen Facial Injectable Introduction
6.8.4 Fibrogen Facial Injectable Revenue in United States Market (2016-2021)
6.8.5 Fibrogen Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Figures, Tables and Charts Available in United States Facial Injectable Market Report & Forecast 2021-2027
List of TablesTable 1. Facial Injectable Market Opportunities & Trends in United States Market
Table 2. Facial Injectable Market Drivers in United States Market
Table 3. Facial Injectable Market Restraints in United States Market
Table 4. Key Players of Facial Injectable in United States Market
Table 5. Top Facial Injectable Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Facial Injectable Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Facial Injectable Revenue Share by Companies, 2016-2021
Table 8. Companies Facial Injectable Product Type
Table 9. List of Tier 1 Facial Injectable Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Facial Injectable Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – United States Facial Injectable Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Facial Injectable Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Facial Injectable Revenue (US$, Mn), 2022-2027
Table 14. By Application – United States Facial Injectable Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Facial Injectable Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Facial Injectable Revenue (US$, Mn), 2022-2027
Table 17. Bloomega BioTechnology Company Details
Table 18. Bloomega BioTechnology Business Overview
Table 19. Bloomega BioTechnology Facial Injectable Product
Table 20. Bloomega BioTechnology Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Bloomega BioTechnology Recent Developments
Table 22. Allergan Company Details
Table 23. Allergan Business Overview
Table 24. Allergan Facial Injectable Product
Table 25. Allergan Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Allergan Recent Developments
Table 27. Merz Pharma Company Details
Table 28. Merz Pharma Business Overview
Table 29. Merz Pharma Facial Injectable Product
Table 30. Merz Pharma Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Merz Pharma Recent Developments
Table 32. Bausch Health Company Details
Table 33. Bausch Health Business Overview
Table 34. Bausch Health Facial Injectable Product
Table 35. Bausch Health Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Bausch Health Recent Developments
Table 37. Galderma Company Details
Table 38. Galderma Business Overview
Table 39. Galderma Facial Injectable Product
Table 40. Galderma Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Galderma Recent Developments
Table 42. Integra Lifesciences Company Details
Table 43. Integra Lifesciences Business Overview
Table 44. Integra Lifesciences Facial Injectable Product
Table 45. Integra Lifesciences Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Integra Lifesciences Recent Developments
Table 47. Tei Biosciences Company Details
Table 48. Tei Biosciences Business Overview
Table 49. Tei Biosciences Facial Injectable Product
Table 50. Tei Biosciences Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Tei Biosciences Recent Developments
Table 52. Fibrogen Company Details
Table 53. Fibrogen Business Overview
Table 54. Fibrogen Facial Injectable Product
Table 55. Fibrogen Facial Injectable Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Fibrogen Recent Developments
List of Figures
Figure 1. Facial Injectable Segment by Type
Figure 2. Facial Injectable Segment by Application
Figure 3. United States Facial Injectable Market Overview: 2020
Figure 4. United States Facial Injectable Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Facial Injectable Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Facial Injectable Revenue in 2020
Figure 7. By Type - United States Facial Injectable Revenue Market Share, 2016-2027
Figure 8. By Application - United States Facial Injectable Revenue Market Share, 2016-2027
Figure 9. Bloomega BioTechnology Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Allergan Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Merz Pharma Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Bausch Health Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Galderma Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Integra Lifesciences Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Tei Biosciences Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Fibrogen Facial Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Keyplayers in United States Facial Injectable Market Report & Forecast 2021-2027
Bloomega BioTechnologyAllergan
Merz Pharma
Bausch Health
Galderma
Integra Lifesciences
Tei Biosciences
Fibrogen